The iQue ® software module for 21 CFR Part 11 ensures next-level iQue ® productivity for regulated laboratories. Designed for speed and actionable results, iQue ® is the instrument of choice for busy ...
ALBUQUERQUE, N.M.--(BUSINESS WIRE)--IntelliCyt, a leading provider of integrated platforms that accelerate drug discovery, antibody screening and immuno-oncology research, today announced record sales ...
IntelliCyt develops innovative, high-throughput, high-content cell- and bead-based screening solutions for use in phenotypic drug discovery, antibody discovery, and in vitro toxicity testing. Founded ...
Sartorius said today it has acquired IntelliCyt for $90 million cash, in a deal that expands the buyer’s portfolio into bioanalytics by adding the developer of cell screening platforms for drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results